/EINPresswire.com/ -- TORONTO, ON--(Marketwired - November 02, 2015) - This webinar is aimed at improving the end-users' understanding of pre-clinical in vivo inflammatory bowel disease (IBD) models, addressing issues associated with the various models currently available. The live broadcast takes place on Friday, November 13, 2015 at 10am EST (3pm GMT).

The presenter, Dr. James Wilson, Principal Scientist at Epistem will provide an informative discussion to enable the audience to select the best model and study design for their research. Dr. Wilson has been working in this field for many years, working with many different biotech and pharmaceutical companies to design and perform studies that address their key questions.

The webinar will review some of the models in use and discuss current practice when running pre-clinical models for inflammatory bowel disease drug development at Epistem. Specifically, there will be an overview of adoptive T cell transfer-mediated chronic colitis and chemically-induced models of acute colitis (DSS- and TNBS-induced colitis).

The following key points will be addressed:

• The pros and cons of each model
• Historical data relating to disease reproducibility
• Performance of reference items / clinical standards
• A summary of typical study designs employed for each model

To learn more about this event visit: Pre-clinical Inflammatory Bowel Disease (IBD) Models

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/10/30/11G069868/Images/epistem-logo_300-401623322273.jpg

Contact:
Dian Razak
Tel: +1 (416) 977-6555 ext 352
Email: drazak@xtalks.com

Epistem is a biotechnology company with a specialist understanding of epithelial tissue and stem cell analyses, operating three distinct business divisions.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.